Clinical trials
Phase 3 Major Depressive Disorder trials in Poland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
51 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 4 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 3 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 7 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 31 |
| Terminated | 10 |
| Recruiting | 7 |
| Active, not recruiting | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Janssen Research & Development, LLC | 9 |
| H. Lundbeck A/S | 6 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 5 |
| AstraZeneca | 3 |
| Eli Lilly and Company | 3 |
| Cybin IRL Limited | 2 |
| Intra-Cellular Therapies, Inc. | 2 |
| Naurex, Inc, an affiliate of Allergan plc | 2 |
| Neumora Therapeutics, Inc. | 2 |
| Neurocrine Biosciences | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Major Depressive Disorder | 51 |
| Depressive Disorder | 10 |
| Mood Disorders | 8 |
| Mental Disorders | 5 |
| Anhedonia | 4 |
| Dysthymic Disorder | 1 |
| Sleep Initiation and Maintenance Disorders | 1 |
Trials
Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.